4-HO-MiPT and 4-AcO-MiPT both come up in the same conversations; they overlap on Serotonin. 4-HO-MiPT: 4-HO-MiPT (4-hydroxy-N-methyl-N-isopropyltryptamine; miprocin) is a synthetic tryptamine psychedelic and a close structural relative of psilocin, differing by an isopropyl group on the side chain. 4-AcO-MiPT: 4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine) is a synthetic tryptamine, the acetate ester of 4-HO-MiPT and a close analog of psilacetin.
4-HO-MiPT (4-hydroxy-N-methyl-N-isopropyltryptamine; miprocin) is a synthetic tryptamine psychedelic and a close structural relative of psilocin, differing by an isopropyl group on the side chain. Its effects derive mainly from potent, efficacious agonism at the 5-HT2A serotonin receptor, with EC50 values in the low-nanomolar range and additional activity across the 5-HT2 family; in the mouse head-twitch model it is a robust psychedelic whose response can be blunted by serotonin transporter inhibition, illustrating how transporter engagement modulates the tryptamine experience. In rats, closely related 4-substituted tryptamines fully substitute for the discriminative stimulus of DOM, consistent with a classic hallucinogen profile. Users often describe it as comparatively gentle and clear-headed, though set and setting remain important.
4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine) is a synthetic tryptamine, the acetate ester of 4-HO-MiPT and a close analog of psilacetin. It is thought to act as a prodrug for the active 4-HO-MiPT, a full agonist at the 5-HT2A serotonin receptor that mediates its psilocybin-like psychedelic effects. In rodent drug-discrimination studies 4-AcO-MiPT fully substitutes for the classic hallucinogen DOM, supporting a shared serotonergic mechanism, and structure-activity work classes it among psilocybin-like tryptamines whose acetate esters appear to behave as prodrugs. Comparative pharmacology of the MiPT series indicates that concurrent serotonin transporter inhibition can blunt psychedelic-like effects, a property relevant across the broader tryptamine family. Human data specific to 4-AcO-MiPT remain limited.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
agonist (via active metabolite)
agonist
agonist
agonist
agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.